Faculty of Health Sciences

The Cancer Grand Challenges works with the global research community and people affected by cancer to identify the 

toughest challenges in cancer research, then dares interdisciplinary, world-class teams to take them on. Cancer Grand Challenges are intended to transform cancer research. This funding opportunity seeks applications that reflect this ambition. Therefore, proposals need to be bold, innovative solutions to the challenges below, and should include evidence that applicants have actively sought out new, perhaps unusual, collaborations, that will bring fresh thinking to these problems. Cancer Grand Challenges awards are not intended to fund research that would be fundable by other response-mode schemes and initiatives. 

Award details:  

International teams are invited to apply for up to $25m in funding. 

Deadlines:  

• Once you have read the guidelines document, check your eligibility by completing the pre-submission questionnaire.  Once your eligibility has been established, an Expression of Interest (EOI) application form will be opened for you. 

• Applying for this funding opportunity involves the PI completing the Expression of Interest (EOI) application on the funder portal (Flexi-Grant) as well as requesting institutional approval via UCT’s electronic Research Administration (eRA) system, prior to submission of the application.  

• PI to initiate an eRA proposal approval request and contact the Departmental Finance Officer no later than: 11 May 2023 

• PI to submit a proposal approval request to the Finance Approver step on eRA no later than: 12 June 2023 

• Deadline for proposal approval request to reach the RC&I step on eRA: 19 June 2023  

• Funder deadline for submission of Expression of Interest (EOI): 22 June 2023 

For more information, click here. 

The National Institutes of Health (NIH) seeks applications for Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional; PAR-20-300 and R21 Clinical Trial Optional; PAR-23-131).

The purpose of this funding opportunity is to support translational and clinical research to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children (including those with disabilities) by:

1. Advancing precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact.

2. Enhancing the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation.

3. Discovering and developing novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children.

Award details:

Deadlines:

For more information, click  here.

Dear UCT Researchers,

The NRF has announced the opening of NRF One call for proposal applications. Please see the attached MS Word list for the NRF calls that are currently open, the internal deadlines and contact person per funding programme.

Please take note of the following:

1. It is of utmost importance that applicants consult the Funding Framework for more detailed information about the funding instrument about the:

• Purpose / theme(s) of the call
• Eligibility criteria (contract staff must be employed at UCT for the duration of the funding period or provide a letter from the HoD)
• Which budget items are funded/not.
• Whether provision has been made for postdoctoral support.
• Application review scorecard.

2. The NRF PG student funding policy was revised w.e.f. 2021 and grant holder linked PG bursaries have been phased out. Students must apply directly to the NRF with your application reference number. The call usually opens in April – please check for the announcement from the PGFO.
3. All applications must be submitted via the new NRF Connect system. Guides on how to register & sync your CV from the old system are available online here. See the attached PDF for how to import outputs from Scopus / ORCID.
4. Applications submitted by the UCT internal deadline will receive review feedback. Proposals received after the UCT internal deadline will only receive technical review.

Attachments:

1. Exporting Output records from NRF submission

2. List of open calls, internal deadlines and contact persons

It is recommended that researchers check the current funding page regularly for up to date information about open funding calls- https://www.uct.ac.za/research-support-hub/funding-contracts/current-funding-opportunities.

The National Institutes of Health (NIH) is soliciting applications for the Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional; RFA-ES-23-007) program. The purpose of this funding opportunity is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs).

This program will support the development of a transdisciplinary research environment to sustain a program of fundamental and applied research to examine the impacts of climate change on health and to develop action-oriented solutions to protect the health of individuals, communities, and nations from the hazards posed by climate change. This opportunity will allow the development of new research teams collaborating with communities and other partners to develop projects that generate data that will build or expand research capacity across a range of thematic scientific areas in support of the four core elements of the NIH’s Initiative in climate heath research: health effects research, health equity, intervention research, and training and capacity building.

Award details:

· Awards are available for three years and offer up to $850,000 for direct costs per year.

Deadlines:

For more information, click here

The Royal Society of Tropical Medicine & Hygiene (RSTMH) is seeking applications for the Early Career Grants Programme. The overall aim of the programme is to encourage and inspire the next generation of global health leaders, innovators, and professionals by providing the opportunity for them to carry out projects which could improve tropical medicine or global health.

Applications can be on any topic related to tropical medicine and global health, from across the research spectrum of lab, translation, implementation, and policy. RSTMH held a webinar on the Early Career Grant application process on 15 February. Please click here to watch the recording of the information session.

Eligibility:

This call is open to early career researchers and global health professionals based anywhere in the world, who have not held more than £5,000 research funding before.

Award details:

Grants of up to £5,000 are available for a period of one year.

Deadlines:

· PI to initiate an eRA proposal approval request and contact the Departmental Finance Officer no later than: 24 March 2023

· PI to submit an eRA proposal approval request to the Finance Approver step on eRA no later than: 24 April 2023

· Funder deadline: 28 April 2023, 10:00 SAST

For more information, click here.

In January 2023, South Africa was admitted as a member of the International Human Frontier Science Program (HFSP) following a competitive application process. The South African Medical Research Council (SAMRC) and the National Research Foundation (NRF) serve as joint institutional members. South Africa is the 16th country to be admitted, and the only country from Africa. HFSP Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. 

Two types of research grants are available: 

Award details:  

• Detailed budgets are not required.  

• Depending on team size, a fixed sum is awarded, to each team, over three years, depending on team size (awarded 2-member teams will receive 300 000 USD and 4-member teams 500 000 USD annually, if all members have their labs in different countries).   

Please adhere to the following SAMRC application deadlines: 

• Compulsory initiation of a Letter of Intent (LOI): 21 March 2023 (8pm SAST) 

For more information, click here.